[
{
  "model": "survey.region",
  "pk": 1,
  "fields": {
    "name": "East",
    "country": 3,
    "created_at": "2016-12-28T20:10:55.914Z"
  }
},
{
  "model": "survey.region",
  "pk": 2,
  "fields": {
    "name": "North",
    "country": 3,
    "created_at": "2016-12-28T20:11:01.434Z"
  }
},
{
  "model": "survey.region",
  "pk": 3,
  "fields": {
    "name": "South",
    "country": 3,
    "created_at": "2017-01-05T13:31:23.717Z"
  }
},
{
  "model": "survey.region",
  "pk": 4,
  "fields": {
    "name": "North",
    "country": 4,
    "created_at": "2017-01-05T13:32:21.206Z"
  }
},
{
  "model": "survey.region",
  "pk": 5,
  "fields": {
    "name": "South",
    "country": 4,
    "created_at": "2017-01-05T13:32:26.215Z"
  }
},
{
  "model": "survey.region",
  "pk": 6,
  "fields": {
    "name": "Centre",
    "country": 4,
    "created_at": "2017-01-05T13:33:10.140Z"
  }
},
{
  "model": "survey.region",
  "pk": 7,
  "fields": {
    "name": "North",
    "country": 5,
    "created_at": "2017-01-05T13:37:41.840Z"
  }
},
{
  "model": "survey.region",
  "pk": 8,
  "fields": {
    "name": "South",
    "country": 5,
    "created_at": "2017-01-05T13:37:48.612Z"
  }
},
{
  "model": "survey.region",
  "pk": 9,
  "fields": {
    "name": "Centre",
    "country": 5,
    "created_at": "2017-01-05T13:37:54.973Z"
  }
},
{
  "model": "survey.organization",
  "pk": 1,
  "fields": {
    "name": "Drug Abuse Specialised Mental Health Centre",
    "created_at": "2016-12-28T20:08:48.538Z"
  }
},
{
  "model": "survey.organization",
  "pk": 2,
  "fields": {
    "name": "Mental Health Centres",
    "created_at": "2016-12-28T20:08:55.070Z"
  }
},
{
  "model": "survey.organization",
  "pk": 3,
  "fields": {
    "name": "Hospital",
    "created_at": "2016-12-28T20:09:04.217Z"
  }
},
{
  "model": "survey.question",
  "pk": 1,
  "fields": {
    "type": "type_two_dependend_fields",
    "field": 1,
    "text": "How many of your Patients under 35 years old with SCZ have Substance abuse?",
    "depends_of": null,
    "dependency_type": null,
    "script": "",
    "created_at": "2016-12-28T20:25:12.476Z"
  }
},
{
  "model": "survey.question",
  "pk": 2,
  "fields": {
    "type": "type_yes_no",
    "field": null,
    "text": "Do you treat patients with SCZ and Substance abuse differently to other Patients with SCZ?",
    "depends_of": null,
    "dependency_type": null,
    "script": "",
    "created_at": "2016-12-28T20:28:23.239Z"
  }
},
{
  "model": "survey.question",
  "pk": 3,
  "fields": {
    "type": "type_multiselect_ordered",
    "field": null,
    "text": "What are the top 3 antipsychotics you use for the treatment of SCZ in Patients with SCZ and Substance abuse in maintenance setting?",
    "depends_of": null,
    "dependency_type": null,
    "script": "",
    "created_at": "2016-12-28T20:29:21.105Z"
  }
},
{
  "model": "survey.question",
  "pk": 4,
  "fields": {
    "type": "type_multiselect_ordered",
    "field": null,
    "text": "What is your rationale to choose one treatment over another?",
    "depends_of": null,
    "dependency_type": null,
    "script": "",
    "created_at": "2016-12-28T20:29:37.680Z"
  }
},
{
  "model": "survey.question",
  "pk": 5,
  "fields": {
    "type": "type_yes_no",
    "field": null,
    "text": "Do you have experience with Aripiprazole for the treatment of SCZ in patients with SCZ and substance abuse?",
    "depends_of": 1,
    "dependency_type": 2,
    "script": "//alert('test');",
    "created_at": "2016-12-28T20:30:42.038Z"
  }
},
{
  "model": "survey.question",
  "pk": 6,
  "fields": {
    "type": "type_multiselect_ordered",
    "field": null,
    "text": "Why would you choose Aripiprazole over another antipsychotic?",
    "depends_of": null,
    "dependency_type": null,
    "script": "",
    "created_at": "2016-12-28T20:31:02.240Z"
  }
},
{
  "model": "survey.question",
  "pk": 7,
  "fields": {
    "type": "type_yes_no",
    "field": null,
    "text": "If you consider your patient population over 35 years old, would any of your answer be different?",
    "depends_of": null,
    "dependency_type": null,
    "script": "",
    "created_at": "2016-12-28T20:31:36.750Z"
  }
},
{
  "model": "survey.question",
  "pk": 8,
  "fields": {
    "type": "type_dependeend_question",
    "field": 2,
    "text": "Out of the last 10 patients with SCZ, how many have Substance abuse?",
    "depends_of": 1,
    "dependency_type": 1,
    "script": "",
    "created_at": "2016-12-28T21:31:27.964Z"
  }
},
{
  "model": "survey.option",
  "pk": 1,
  "fields": {
    "question": 3,
    "value": "Ari-oral",
    "ordering": 0,
    "created_at": "2016-12-28T21:32:56.080Z"
  }
},
{
  "model": "survey.option",
  "pk": 2,
  "fields": {
    "question": 3,
    "value": "Ari-LAI",
    "ordering": 0,
    "created_at": "2016-12-28T21:33:05.286Z"
  }
},
{
  "model": "survey.option",
  "pk": 3,
  "fields": {
    "question": 3,
    "value": "Resperidol-oral",
    "ordering": 0,
    "created_at": "2016-12-28T21:33:18.702Z"
  }
},
{
  "model": "survey.option",
  "pk": 4,
  "fields": {
    "question": 3,
    "value": "Resperidol-LAI",
    "ordering": 0,
    "created_at": "2016-12-28T21:33:26.478Z"
  }
},
{
  "model": "survey.option",
  "pk": 5,
  "fields": {
    "question": 3,
    "value": "Quetapin-oral",
    "ordering": 0,
    "created_at": "2016-12-28T21:33:34.413Z"
  }
},
{
  "model": "survey.option",
  "pk": 6,
  "fields": {
    "question": 3,
    "value": "Aloperidol-oral",
    "ordering": 0,
    "created_at": "2016-12-28T21:33:42.062Z"
  }
},
{
  "model": "survey.option",
  "pk": 7,
  "fields": {
    "question": 3,
    "value": "Aloperidol-LAI",
    "ordering": 0,
    "created_at": "2016-12-28T21:33:56.801Z"
  }
},
{
  "model": "survey.option",
  "pk": 8,
  "fields": {
    "question": 4,
    "value": "Age",
    "ordering": 0,
    "created_at": "2016-12-28T21:35:39.053Z"
  }
},
{
  "model": "survey.option",
  "pk": 9,
  "fields": {
    "question": 4,
    "value": "Mechanism of Action",
    "ordering": 0,
    "created_at": "2016-12-28T21:35:56.827Z"
  }
},
{
  "model": "survey.option",
  "pk": 10,
  "fields": {
    "question": 4,
    "value": "Preference of the patients",
    "ordering": 0,
    "created_at": "2016-12-28T21:36:05.528Z"
  }
},
{
  "model": "survey.option",
  "pk": 11,
  "fields": {
    "question": 4,
    "value": "Efficacy profile",
    "ordering": 0,
    "created_at": "2016-12-28T21:36:18.150Z"
  }
},
{
  "model": "survey.option",
  "pk": 12,
  "fields": {
    "question": 4,
    "value": "Tolerability profile",
    "ordering": 0,
    "created_at": "2016-12-28T21:36:27.935Z"
  }
},
{
  "model": "survey.option",
  "pk": 13,
  "fields": {
    "question": 4,
    "value": "Health care system specific",
    "ordering": 0,
    "created_at": "2016-12-28T21:36:36.514Z"
  }
},
{
  "model": "survey.option",
  "pk": 14,
  "fields": {
    "question": 4,
    "value": "Pre-dominancy of Symptoms",
    "ordering": 0,
    "created_at": "2016-12-28T21:36:46.550Z"
  }
},
{
  "model": "survey.option",
  "pk": 15,
  "fields": {
    "question": 6,
    "value": "Age",
    "ordering": 0,
    "created_at": "2016-12-28T21:39:01.682Z"
  }
},
{
  "model": "survey.option",
  "pk": 16,
  "fields": {
    "question": 6,
    "value": "Mechanism of Action",
    "ordering": 0,
    "created_at": "2016-12-28T21:39:16.652Z"
  }
},
{
  "model": "survey.option",
  "pk": 17,
  "fields": {
    "question": 6,
    "value": "Preference of the patients",
    "ordering": 0,
    "created_at": "2016-12-28T21:39:24.884Z"
  }
},
{
  "model": "survey.option",
  "pk": 18,
  "fields": {
    "question": 6,
    "value": "Efficacy profile",
    "ordering": 0,
    "created_at": "2016-12-28T21:39:32.141Z"
  }
},
{
  "model": "survey.option",
  "pk": 19,
  "fields": {
    "question": 6,
    "value": "Tolerability profile",
    "ordering": 0,
    "created_at": "2016-12-28T21:39:39.970Z"
  }
},
{
  "model": "survey.option",
  "pk": 20,
  "fields": {
    "question": 6,
    "value": "Health care system specific",
    "ordering": 0,
    "created_at": "2016-12-28T21:39:47.202Z"
  }
},
{
  "model": "survey.option",
  "pk": 21,
  "fields": {
    "question": 6,
    "value": "Pre-dominancy of Symptoms",
    "ordering": 0,
    "created_at": "2016-12-28T21:39:57.975Z"
  }
},
{
  "model": "survey.option",
  "pk": 22,
  "fields": {
    "question": 7,
    "value": "Patients with SCZ with concomitant Substance use/abuse on a daily basis or several times per week (not Occasional/Recreational)",
    "ordering": 0,
    "created_at": "2016-12-28T21:41:50.553Z"
  }
},
{
  "model": "survey.option",
  "pk": 23,
  "fields": {
    "question": 7,
    "value": "Substance abuse including Drugs and Alcohol",
    "ordering": 0,
    "created_at": "2016-12-28T21:42:48.730Z"
  }
},
{
  "model": "survey.option",
  "pk": 24,
  "fields": {
    "question": 3,
    "value": "Paliperidone-oral",
    "ordering": 0,
    "created_at": "2017-01-05T13:49:10.380Z"
  }
},
{
  "model": "survey.option",
  "pk": 25,
  "fields": {
    "question": 3,
    "value": "Paliperidone-LAI",
    "ordering": 0,
    "created_at": "2017-01-05T13:49:21.085Z"
  }
},
{
  "model": "survey.survey",
  "pk": 1,
  "fields": {
    "name": "Test",
    "active": true,
    "created_at": "2016-12-28T22:01:34.162Z"
  }
},
{
  "model": "survey.surveyitem",
  "pk": 1,
  "fields": {
    "survey": 1,
    "question": 1,
    "ordering": 1,
    "created_at": "2016-12-28T22:01:57.556Z"
  }
},
{
  "model": "survey.surveyitem",
  "pk": 2,
  "fields": {
    "survey": 1,
    "question": 2,
    "ordering": 1,
    "created_at": "2016-12-28T22:02:06.659Z"
  }
},
{
  "model": "survey.surveyitem",
  "pk": 3,
  "fields": {
    "survey": 1,
    "question": 3,
    "ordering": 1,
    "created_at": "2016-12-28T22:02:11.828Z"
  }
},
{
  "model": "survey.surveyitem",
  "pk": 4,
  "fields": {
    "survey": 1,
    "question": 4,
    "ordering": 1,
    "created_at": "2016-12-28T22:02:24.077Z"
  }
},
{
  "model": "survey.surveyitem",
  "pk": 5,
  "fields": {
    "survey": 1,
    "question": 5,
    "ordering": 1,
    "created_at": "2016-12-28T22:02:32.121Z"
  }
},
{
  "model": "survey.surveyitem",
  "pk": 6,
  "fields": {
    "survey": 1,
    "question": 6,
    "ordering": 1,
    "created_at": "2016-12-28T22:02:37.154Z"
  }
},
{
  "model": "survey.surveyitem",
  "pk": 7,
  "fields": {
    "survey": 1,
    "question": 7,
    "ordering": 1,
    "created_at": "2016-12-28T22:02:42.379Z"
  }
},
{
  "model": "survey.hcpcategory",
  "pk": 1,
  "fields": {
    "name": "KOL",
    "created_at": "2016-12-29T23:28:37.942Z"
  }
},
{
  "model": "survey.hcpcategory",
  "pk": 2,
  "fields": {
    "name": "Rising Star",
    "created_at": "2016-12-29T23:28:44.255Z"
  }
},
{
  "model": "survey.hcpcategory",
  "pk": 3,
  "fields": {
    "name": "Other HCP",
    "created_at": "2016-12-29T23:28:49.367Z"
  }
},
{
  "model": "survey.answer",
  "pk": 1,
  "fields": {
    "user": 1,
    "country": 3,
    "region": 2,
    "organization": 2,
    "hcp_category": 1,
    "survey": 1,
    "data": {},
    "created_at": "2016-12-30T12:52:47.544Z"
  }
},
{
  "model": "survey.answer",
  "pk": 2,
  "fields": {
    "user": 1,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 1,
    "survey": 1,
    "data": {
      "data[1][main]": [
        ""
      ],
      "data[6][other]": [
        ""
      ],
      "data[4][other]": [
        ""
      ],
      "data[7][other]": [
        ""
      ],
      "data[1][additional]": [
        ""
      ],
      "csrfmiddlewaretoken": [
        "mTe2fHFIi0WkQcf6fdeX6xQRmI9ObjnrHzfgsUYDZ8ahPpMDYQ3pB9Lvu9c35udr"
      ],
      "data[3][other]": [
        ""
      ]
    },
    "created_at": "2016-12-30T15:57:48.514Z"
  }
},
{
  "model": "survey.answer",
  "pk": 3,
  "fields": {
    "user": 1,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 1,
    "survey": 1,
    "data": {},
    "created_at": "2016-12-31T02:26:07.906Z"
  }
},
{
  "model": "survey.answer",
  "pk": 4,
  "fields": {
    "user": 1,
    "country": 3,
    "region": 2,
    "organization": 3,
    "hcp_category": 1,
    "survey": 1,
    "data": {
      "data[7][other]": [
        ""
      ],
      "data[1][main]": [
        ""
      ],
      "data[4][other]": [
        ""
      ],
      "data[6][other]": [
        ""
      ],
      "data[1][additional]": [
        ""
      ],
      "csrfmiddlewaretoken": [
        "SQatEcIRWq4pUajcu7RBy8xPaJ82EYGadwbHRp1MDyimTnQJdKG33Kstiabhy9wa"
      ],
      "data[3][other]": [
        ""
      ],
      "data[6][]": [
        "Preference of the patients",
        "Health care system specific",
        "Tolerability profile",
        "Pre-dominancy of Symptoms"
      ]
    },
    "created_at": "2016-12-31T10:34:21.766Z"
  }
},
{
  "model": "survey.answer",
  "pk": 5,
  "fields": {
    "user": 1,
    "country": 3,
    "region": 2,
    "organization": 2,
    "hcp_category": 1,
    "survey": 1,
    "data": {
      "data[4][other]": [
        ""
      ],
      "data[7][other]": [
        ""
      ],
      "data[1][additional]": [
        ""
      ],
      "data[3][other]": [
        ""
      ],
      "data[6][]": [
        "Mechanism of Action",
        "Health care system specific",
        "Tolerability profile"
      ],
      "data[4][]": [
        "Preference of the patients",
        "Tolerability profile"
      ],
      "data[5]": [
        "No"
      ],
      "data[7][]": [
        "Patients with SCZ with concomitant Substance use/abuse on a daily basis or several times per week (not Occasional/Recreational)"
      ],
      "csrfmiddlewaretoken": [
        "B6kact0CfQemdZ5HK4K9PbBgh7mJ2FVWWMlopGjxWYsjccCetHzBkNwUpypYWQLW"
      ],
      "data[6][other]": [
        ""
      ],
      "data[3][]": [
        "Quetapin-oral",
        "Aloperidol-LAI"
      ],
      "data[1][main]": [
        ""
      ]
    },
    "created_at": "2016-12-31T10:43:12.823Z"
  }
},
{
  "model": "survey.answer",
  "pk": 6,
  "fields": {
    "user": 1,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 2,
    "survey": 1,
    "data": {
      "data[2]": [
        "Yes"
      ],
      "data[4][other]": [
        ""
      ],
      "data[7][other]": [
        ""
      ],
      "data[1][additional]": [
        "4"
      ],
      "data[3][other]": [
        ""
      ],
      "data[6][]": [
        "Age",
        "Health care system specific",
        "Preference of the patients"
      ],
      "data[3][]": [
        "Ari-oral",
        "Resperidol-oral",
        "Quetapin-oral"
      ],
      "data[4][]": [
        "Age",
        "Efficacy profile",
        "Health care system specific"
      ],
      "data[7][]": [
        "Substance abuse including Drugs and Alcohol"
      ],
      "data[6][other]": [
        ""
      ],
      "csrfmiddlewaretoken": [
        "FFrSoYmETi5GjLzEJEiozIBDqQ2qLloD0ls6BbFzAqjDiY6bsh7Q4kwhyh5FFweD"
      ],
      "data[1][main]": [
        "22"
      ]
    },
    "created_at": "2016-12-31T10:46:56.391Z"
  }
},
{
  "model": "survey.answer",
  "pk": 7,
  "fields": {
    "user": 1,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 1,
    "survey": 1,
    "data": {
      "data[7][other]": [
        ""
      ],
      "data[1][main]": [
        "33"
      ],
      "data[4][other]": [
        ""
      ],
      "data[1][additional]": [
        ""
      ],
      "data[6][]": [
        "Health care system specific"
      ],
      "data[6][other]": [
        ""
      ],
      "data[3][]": [
        "Quetapin-oral",
        "Aloperidol-oral"
      ],
      "data[3][other]": [
        ""
      ],
      "csrfmiddlewaretoken": [
        "QPNLuOR9ehEhnEDVl6IV6jOViNGqh1Q8bvOZH1a4VpSemRas4JxnBVJzqeJFbcG8"
      ]
    },
    "created_at": "2017-01-02T10:52:51.382Z"
  }
},
{
  "model": "survey.answer",
  "pk": 8,
  "fields": {
    "user": 1,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 1,
    "survey": 1,
    "data": {
      "data[3][other]": [
        ""
      ],
      "data[7][other]": [
        ""
      ],
      "csrfmiddlewaretoken": [
        "qCZ8TkoE9iTCvXJwRVTdUoa61BkpFC3rYAtp1ziVpRt2eNtF1LiXZXAP5OTIqPmP"
      ],
      "data[4][]": [
        "Mechanism of Action",
        "Preference of the patients"
      ],
      "data[6][]": [
        "Preference of the patients"
      ],
      "data[1][additional]": [
        ""
      ],
      "data[4][other]": [
        ""
      ],
      "data[6][other]": [
        ""
      ],
      "data[3][]": [
        "Ari-oral"
      ],
      "data[1][main]": [
        "33"
      ],
      "data[2]": [
        "No"
      ]
    },
    "created_at": "2017-01-02T12:22:17.944Z"
  }
},
{
  "model": "survey.answer",
  "pk": 9,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 2,
    "organization": 3,
    "hcp_category": 2,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-02T12:56:44.881Z"
  }
},
{
  "model": "survey.answer",
  "pk": 10,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 1,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-02T12:57:23.233Z"
  }
},
{
  "model": "survey.answer",
  "pk": 11,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 3,
    "hcp_category": 1,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-02T13:31:22.118Z"
  }
},
{
  "model": "survey.answer",
  "pk": 12,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 3,
    "hcp_category": 3,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-02T14:20:46.354Z"
  }
},
{
  "model": "survey.answer",
  "pk": 13,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 1,
    "survey": 1,
    "data": {
      "data[7][other]": [
        ""
      ],
      "data[1][main]": [
        "66"
      ],
      "data[4][other]": [
        ""
      ],
      "data[6][other]": [
        ""
      ],
      "data[1][additional]": [
        "76"
      ],
      "csrfmiddlewaretoken": [
        "QOyXhKBCtNzuEY25UhRNgjsEnOxR6xm64oSddP9I42d7wyumHtVIbXYQAgIIgUmM"
      ],
      "data[3][other]": [
        ""
      ],
      "data[2]": [
        "Yes"
      ]
    },
    "created_at": "2017-01-02T14:40:40.248Z"
  }
},
{
  "model": "survey.answer",
  "pk": 14,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 2,
    "hcp_category": 2,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-02T14:44:00.936Z"
  }
},
{
  "model": "survey.answer",
  "pk": 15,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 2,
    "organization": 3,
    "hcp_category": 2,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-02T15:57:20.440Z"
  }
},
{
  "model": "survey.answer",
  "pk": 16,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 2,
    "hcp_category": 2,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-02T16:02:34.435Z"
  }
},
{
  "model": "survey.answer",
  "pk": 17,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 1,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-02T18:20:00.268Z"
  }
},
{
  "model": "survey.answer",
  "pk": 18,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 1,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-03T12:44:41.241Z"
  }
},
{
  "model": "survey.answer",
  "pk": 19,
  "fields": {
    "user": 1,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 1,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-03T13:04:35.971Z"
  }
},
{
  "model": "survey.answer",
  "pk": 20,
  "fields": {
    "user": 1,
    "country": 3,
    "region": 2,
    "organization": 2,
    "hcp_category": 1,
    "survey": 1,
    "data": {
      "data[1][main]": [
        "100"
      ],
      "data[6][other]": [
        "fff"
      ],
      "data[4][other]": [
        "xxx,eee,mmm"
      ],
      "data[7][other]": [
        ""
      ],
      "data[1][additional]": [
        ""
      ],
      "csrfmiddlewaretoken": [
        "4uzstLKxAvQ22DtMJq5cEnbelOfGxuBKuE34PuZ4pqwdJhQE1rtuWZqWFMHpcq75"
      ],
      "data[3][other]": [
        ""
      ]
    },
    "created_at": "2017-01-03T20:56:45.318Z"
  }
},
{
  "model": "survey.answer",
  "pk": 21,
  "fields": {
    "user": 1,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 3,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-03T20:59:12.683Z"
  }
},
{
  "model": "survey.answer",
  "pk": 22,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 2,
    "hcp_category": 2,
    "survey": 1,
    "data": {
      "data[3][other]": [
        "Test,Tttt fff,Ht,jjj"
      ],
      "data[7][other]": [
        ""
      ],
      "csrfmiddlewaretoken": [
        "DW94ACLWeOVe9UMLoibcsTmbBPKaCB8Lc4TJJYzV2xZbiuveY7r88AhrEAuG20wY"
      ],
      "data[5]": [
        "Yes"
      ],
      "data[6][]": [
        "Age",
        "Efficacy profile",
        "Tolerability profile",
        "Pre-dominancy of Symptoms"
      ],
      "data[1][additional]": [
        "9"
      ],
      "data[4][other]": [
        ""
      ],
      "data[6][other]": [
        ""
      ],
      "data[3][]": [
        "Quetapin-oral",
        "Resperidol-oral",
        "Aloperidol-LAI",
        "Aloperidol-oral",
        "Resperidol-LAI"
      ],
      "data[4][]": [
        "Efficacy profile",
        "Preference of the patients",
        "Age"
      ],
      "data[2]": [
        "No"
      ]
    },
    "created_at": "2017-01-04T08:39:17.492Z"
  }
},
{
  "model": "survey.answer",
  "pk": 23,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 2,
    "hcp_category": 2,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-04T08:45:25.879Z"
  }
},
{
  "model": "survey.answer",
  "pk": 24,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 1,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-04T08:49:29.316Z"
  }
},
{
  "model": "survey.answer",
  "pk": 25,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 3,
    "hcp_category": 2,
    "survey": 1,
    "data": {
      "data[3][other]": [
        ""
      ],
      "data[7][other]": [
        ""
      ],
      "csrfmiddlewaretoken": [
        "PUK1yyeX1LgViE9qIVKOYYkzASajAKGMzEIeR6qlBI8DideONcw1KHomTw1B86Wc"
      ],
      "data[5]": [
        "No"
      ],
      "data[6][]": [
        "Mechanism of Action",
        "Tolerability profile",
        "Preference of the patients"
      ],
      "data[1][additional]": [
        "2"
      ],
      "data[4][other]": [
        ""
      ],
      "data[6][other]": [
        ""
      ],
      "data[3][]": [
        "Ari-LAI",
        "Quetapin-oral",
        "Aloperidol-LAI",
        "Resperidol-oral"
      ],
      "data[4][]": [
        "Efficacy profile",
        "Health care system specific",
        "Mechanism of Action"
      ],
      "data[2]": [
        "No"
      ]
    },
    "created_at": "2017-01-04T08:50:15.468Z"
  }
},
{
  "model": "survey.answer",
  "pk": 26,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 2,
    "organization": 2,
    "hcp_category": 1,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-04T08:52:34.359Z"
  }
},
{
  "model": "survey.answer",
  "pk": 27,
  "fields": {
    "user": 1,
    "country": 3,
    "region": 1,
    "organization": 3,
    "hcp_category": 2,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-04T08:56:29.239Z"
  }
},
{
  "model": "survey.answer",
  "pk": 28,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 2,
    "hcp_category": 2,
    "survey": 1,
    "data": {
      "data[3][other]": [
        ""
      ],
      "data[7][other]": [
        ""
      ],
      "csrfmiddlewaretoken": [
        "znkRKOJgfIWKvmkTtA9186y3ODchouHWhg0fx5A5EtWyZTUMRSBAiyQegmq0Gskx"
      ],
      "data[4][]": [
        "Mechanism of Action",
        "Health care system specific",
        "Preference of the patients",
        "Pre-dominancy of Symptoms",
        "Efficacy profile",
        "Age"
      ],
      "data[6][]": [
        "Age",
        "Efficacy profile",
        "Tolerability profile"
      ],
      "data[1][additional]": [
        ""
      ],
      "data[4][other]": [
        ""
      ],
      "data[6][other]": [
        ""
      ],
      "data[3][]": [
        "Resperidol-LAI",
        "Resperidol-oral",
        "Aloperidol-oral",
        "Aloperidol-LAI",
        "Ari-LAI",
        "Ari-oral"
      ],
      "data[1][main]": [
        "11"
      ],
      "data[2]": [
        "No"
      ]
    },
    "created_at": "2017-01-04T08:59:07.493Z"
  }
},
{
  "model": "survey.answer",
  "pk": 29,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 2,
    "hcp_category": 2,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-04T09:00:58.172Z"
  }
},
{
  "model": "survey.answer",
  "pk": 30,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 3,
    "hcp_category": 3,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-04T09:02:45.486Z"
  }
},
{
  "model": "survey.answer",
  "pk": 31,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 2,
    "hcp_category": 1,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-04T12:01:35.681Z"
  }
},
{
  "model": "survey.answer",
  "pk": 32,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 3,
    "hcp_category": 3,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-04T12:41:39.699Z"
  }
},
{
  "model": "survey.answer",
  "pk": 33,
  "fields": {
    "user": 1,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 1,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-04T13:04:14.143Z"
  }
},
{
  "model": "survey.answer",
  "pk": 34,
  "fields": {
    "user": 1,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 1,
    "survey": 1,
    "data": {
      "data[7][other]": [
        ""
      ],
      "csrfmiddlewaretoken": [
        "aKonpOuCtCF6Ou2EDEhgaeOwNI2urQQ2ieFVBLN1F5zHG2mw0iyshgad8DzDbjmb"
      ],
      "data[3][other]": [
        ""
      ],
      "data[7][]": [
        "Patients with SCZ with concomitant Substance use/abuse on a daily basis or several times per week (not Occasional/Recreational)"
      ],
      "data[1][additional]": [
        "4"
      ],
      "data[4][other]": [
        ""
      ],
      "data[6][]": [
        "Age",
        "Efficacy profile",
        "Health care system specific"
      ],
      "data[6][other]": [
        ""
      ],
      "data[3][]": [
        "Ari-oral",
        "Resperidol-LAI"
      ],
      "data[4][]": [
        "Tolerability profile",
        "Pre-dominancy of Symptoms"
      ],
      "data[2]": [
        "Yes"
      ]
    },
    "created_at": "2017-01-04T19:26:26.398Z"
  }
},
{
  "model": "survey.answer",
  "pk": 35,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 1,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-04T22:25:14.153Z"
  }
},
{
  "model": "survey.answer",
  "pk": 36,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 2,
    "hcp_category": 3,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-04T22:30:19.446Z"
  }
},
{
  "model": "survey.answer",
  "pk": 37,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 2,
    "organization": 3,
    "hcp_category": 3,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-04T22:31:44.066Z"
  }
},
{
  "model": "survey.answer",
  "pk": 38,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 2,
    "hcp_category": 3,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-04T22:53:20.336Z"
  }
},
{
  "model": "survey.answer",
  "pk": 39,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 2,
    "hcp_category": 3,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-04T22:54:14.100Z"
  }
},
{
  "model": "survey.answer",
  "pk": 40,
  "fields": {
    "user": 1,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 3,
    "survey": 1,
    "data": {
      "data[7][other]": [
        ""
      ],
      "data[4][other]": [
        ""
      ],
      "data[1][additional]": [
        "5"
      ],
      "data[6][]": [
        "Preference of the patients",
        "Mechanism of Action"
      ],
      "data[6][other]": [
        ""
      ],
      "csrfmiddlewaretoken": [
        "E9sJ2nlHn3Tr5r1WMSDV5WhF5I6Az2WuMDJhekE6zwN2XZlO9wU7cYDmqDDJjvsD"
      ],
      "data[3][other]": [
        ""
      ],
      "data[2]": [
        "No"
      ]
    },
    "created_at": "2017-01-05T09:58:47.176Z"
  }
},
{
  "model": "survey.answer",
  "pk": 41,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 2,
    "hcp_category": 3,
    "survey": 1,
    "data": {
      "data[2]": [
        "No"
      ],
      "data[4][other]": [
        ""
      ],
      "data[7][other]": [
        ""
      ],
      "data[1][additional]": [
        ""
      ],
      "data[3][other]": [
        "sss asd"
      ],
      "data[6][]": [
        "Preference of the patients",
        "Efficacy profile",
        "Tolerability profile",
        "Health care system specific",
        "Pre-dominancy of Symptoms"
      ],
      "data[3][]": [
        "Aloperidol-oral",
        "Ari-LAI",
        "Ari-oral",
        "Resperidol-LAI",
        "Resperidol-oral"
      ],
      "data[4][]": [
        "Mechanism of Action",
        "Tolerability profile",
        "Age",
        "Health care system specific",
        "Efficacy profile"
      ],
      "data[7][]": [
        "Patients with SCZ with concomitant Substance use/abuse on a daily basis or several times per week (not Occasional/Recreational)",
        "Substance abuse including Drugs and Alcohol"
      ],
      "data[6][other]": [
        ""
      ],
      "csrfmiddlewaretoken": [
        "3NWWKf5zZ7IXP7H3oZffGRsct53Jx99KQMjwxOQSNgFslONDPmatJvkUKPOktqfy"
      ],
      "data[1][main]": [
        "11"
      ]
    },
    "created_at": "2017-01-05T10:09:38.578Z"
  }
},
{
  "model": "survey.answer",
  "pk": 42,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 3,
    "hcp_category": 1,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-05T10:13:04.644Z"
  }
},
{
  "model": "survey.answer",
  "pk": 43,
  "fields": {
    "user": 1,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 1,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-05T10:17:05.120Z"
  }
},
{
  "model": "survey.answer",
  "pk": 44,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 1,
    "survey": 1,
    "data": {
      "data[2]": [
        "No"
      ],
      "data[4][other]": [
        "Ttttt"
      ],
      "data[7][other]": [
        ""
      ],
      "data[1][additional]": [
        ""
      ],
      "data[3][other]": [
        ""
      ],
      "data[3][]": [
        "Resperidol-LAI",
        "Quetapin-oral"
      ],
      "data[4][]": [
        "Age",
        "Efficacy profile",
        "Health care system specific"
      ],
      "data[5]": [
        "No"
      ],
      "data[6][]": [
        "Mechanism of Action",
        "Efficacy profile",
        "Tolerability profile",
        "Age",
        "Pre-dominancy of Symptoms",
        "Health care system specific"
      ],
      "data[6][other]": [
        ""
      ],
      "csrfmiddlewaretoken": [
        "6zAaY4RBQQPEGEybQBOsQ19vuynx9B0U6YrDpRU5kqguLv6veitIaDQmiO05lIl3"
      ],
      "data[1][main]": [
        "66"
      ]
    },
    "created_at": "2017-01-05T10:24:22.668Z"
  }
},
{
  "model": "survey.answer",
  "pk": 45,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 2,
    "organization": 2,
    "hcp_category": 3,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-05T10:31:25.221Z"
  }
},
{
  "model": "survey.answer",
  "pk": 46,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 1,
    "survey": 1,
    "data": {
      "data[7][other]": [
        ""
      ],
      "csrfmiddlewaretoken": [
        "mOZqqkRw2FEoBW8xuK4QhKa2AEovPD9W4yPK4cX1VtCPqnGLwtBliwEE3hGMYNUY"
      ],
      "data[3][other]": [
        ""
      ],
      "data[7][]": [
        "Patients with SCZ with concomitant Substance use/abuse on a daily basis or several times per week (not Occasional/Recreational)"
      ],
      "data[1][additional]": [
        "5"
      ],
      "data[4][other]": [
        ""
      ],
      "data[6][]": [
        "Mechanism of Action",
        "Preference of the patients"
      ],
      "data[6][other]": [
        ""
      ],
      "data[3][]": [
        "Ari-oral",
        "Resperidol-LAI",
        "Quetapin-oral",
        "Aloperidol-LAI",
        "Resperidol-oral",
        "Ari-LAI"
      ],
      "data[4][]": [
        "Age",
        "Preference of the patients",
        "Health care system specific"
      ],
      "data[2]": [
        "No"
      ]
    },
    "created_at": "2017-01-05T10:32:01.886Z"
  }
},
{
  "model": "survey.answer",
  "pk": 47,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 2,
    "organization": 2,
    "hcp_category": 2,
    "survey": 1,
    "data": {
      "data[7][other]": [
        "something really bad"
      ],
      "csrfmiddlewaretoken": [
        "NZhnwQ81RtWXJ9rAP3jThVuJgmjX1SenFDty6b7y7G5wHUTHfZHm9oNZmbEN0kj1"
      ],
      "data[3][other]": [
        "something,I do not know how to enter,ok there is a keyboard"
      ],
      "data[7][]": [
        "Patients with SCZ with concomitant Substance use/abuse on a daily basis or several times per week (not Occasional/Recreational)"
      ],
      "data[1][additional]": [
        "5"
      ],
      "data[4][other]": [
        ""
      ],
      "data[6][]": [
        "Preference of the patients",
        "Tolerability profile",
        "Health care system specific",
        "Efficacy profile",
        "Mechanism of Action",
        "Pre-dominancy of Symptoms",
        "Age"
      ],
      "data[6][other]": [
        ""
      ],
      "data[3][]": [
        "Ari-oral",
        "Quetapin-oral",
        "Aloperidol-oral"
      ],
      "data[4][]": [
        "Efficacy profile",
        "Pre-dominancy of Symptoms",
        "Preference of the patients",
        "Mechanism of Action",
        "Age",
        "Tolerability profile",
        "Health care system specific"
      ],
      "data[2]": [
        "No"
      ]
    },
    "created_at": "2017-01-05T10:44:13.080Z"
  }
},
{
  "model": "survey.answer",
  "pk": 48,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 3,
    "survey": 1,
    "data": {
      "data[3][other]": [
        ""
      ],
      "data[7][other]": [
        ""
      ],
      "csrfmiddlewaretoken": [
        "KFXQbBSaH1pQvz0Stil3w6HFaEQILFA1hrpL6eIbZANTlK0GZrXKnZP2eFml4DmR"
      ],
      "data[5]": [
        "No"
      ],
      "data[6][]": [
        "Tolerability profile",
        "Health care system specific",
        "Preference of the patients",
        "Efficacy profile"
      ],
      "data[1][additional]": [
        ""
      ],
      "data[4][other]": [
        "Hhh,Hhhg hhb"
      ],
      "data[6][other]": [
        ""
      ],
      "data[3][]": [
        "Resperidol-LAI",
        "Ari-LAI",
        "Aloperidol-oral",
        "Aloperidol-LAI"
      ],
      "data[1][main]": [
        "66"
      ],
      "data[2]": [
        "No"
      ]
    },
    "created_at": "2017-01-05T10:49:27.960Z"
  }
},
{
  "model": "survey.answer",
  "pk": 49,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 1,
    "survey": 1,
    "data": {
      "data[7][]": [
        "Patients with SCZ with concomitant Substance use/abuse on a daily basis or several times per week (not Occasional/Recreational)"
      ],
      "data[4][other]": [
        ""
      ],
      "data[7][other]": [
        ""
      ],
      "data[1][additional]": [
        ""
      ],
      "data[3][other]": [
        ""
      ],
      "data[2]": [
        "No"
      ],
      "data[4][]": [
        "Tolerability profile",
        "Health care system specific",
        "Preference of the patients"
      ],
      "data[5]": [
        "No"
      ],
      "data[6][]": [
        "Preference of the patients",
        "Tolerability profile",
        "Health care system specific"
      ],
      "csrfmiddlewaretoken": [
        "KJSlMPezX7S5f8EUzIB5oTDGaMlmTbbbGG5VlLur33mffj6rsGqd9C8IOfVW3Y2P"
      ],
      "data[6][other]": [
        ""
      ],
      "data[3][]": [
        "Ari-LAI",
        "Quetapin-oral",
        "Resperidol-LAI",
        "Aloperidol-LAI",
        "Aloperidol-oral"
      ],
      "data[1][main]": [
        "68"
      ]
    },
    "created_at": "2017-01-05T10:58:19.394Z"
  }
},
{
  "model": "survey.answer",
  "pk": 50,
  "fields": {
    "user": 1,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 3,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-05T12:05:24.467Z"
  }
},
{
  "model": "survey.answer",
  "pk": 51,
  "fields": {
    "user": 1,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 1,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-05T12:16:19.258Z"
  }
},
{
  "model": "survey.answer",
  "pk": 52,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 2,
    "hcp_category": 3,
    "survey": 1,
    "data": {
      "data[7]": [
        "No"
      ],
      "csrfmiddlewaretoken": [
        "rOrowb7E3oMdvA88XPNoVeeD6hiwoK147Sz7hHHtSKUc15JZ7UpDvSyODfeOGmOK"
      ],
      "data[4][other]": [
        ""
      ],
      "data[6][other]": [
        ""
      ],
      "data[1][additional]": [
        "4"
      ],
      "data[3][]": [
        "Quetapin-oral",
        "Aloperidol-oral",
        "Aloperidol-LAI",
        "Ari-oral",
        "Resperidol-LAI"
      ],
      "data[3][other]": [
        ""
      ],
      "data[2]": [
        "No"
      ]
    },
    "created_at": "2017-01-05T12:40:30.606Z"
  }
},
{
  "model": "survey.answer",
  "pk": 53,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 2,
    "hcp_category": 3,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-05T12:41:55.571Z"
  }
},
{
  "model": "survey.answer",
  "pk": 54,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 2,
    "hcp_category": 3,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-05T12:41:56.578Z"
  }
},
{
  "model": "survey.answer",
  "pk": 55,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 1,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-05T12:43:25.516Z"
  }
},
{
  "model": "survey.answer",
  "pk": 56,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 1,
    "survey": 1,
    "data": {
      "data[7]": [
        "No"
      ],
      "csrfmiddlewaretoken": [
        "v5iyVKfwLdRxHxkDe4wwtE4iX9SrH0b9zhPQ5lTzypWdNQH37n4FLVtYSJHguFjY"
      ],
      "data[3][other]": [
        ""
      ],
      "data[6][]": [
        "Mechanism of Action",
        "Health care system specific",
        "Preference of the patients",
        "Tolerability profile"
      ],
      "data[1][additional]": [
        "7"
      ],
      "data[4][other]": [
        ""
      ],
      "data[6][other]": [
        "Hhhg ooooo"
      ],
      "data[3][]": [
        "Ari-LAI",
        "Ari-oral"
      ],
      "data[4][]": [
        "Mechanism of Action",
        "Preference of the patients",
        "Efficacy profile",
        "Tolerability profile"
      ],
      "data[2]": [
        "Yes"
      ]
    },
    "created_at": "2017-01-05T13:20:02.583Z"
  }
},
{
  "model": "survey.answer",
  "pk": 57,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 1,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-05T13:24:21.556Z"
  }
},
{
  "model": "survey.answer",
  "pk": 58,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 2,
    "hcp_category": 3,
    "survey": 1,
    "data": {
      "data[1][main]": [
        ""
      ],
      "data[4][other]": [
        ""
      ],
      "data[6][other]": [
        ""
      ],
      "data[1][additional]": [
        ""
      ],
      "csrfmiddlewaretoken": [
        "vaGGajCIgLvqKkWPKytfUqZTPwdMRFN9zmdYkUgL3XA6QDjfDR1ocHozK62BEkVY"
      ],
      "data[3][other]": [
        ""
      ],
      "data[2]": [
        "No"
      ]
    },
    "created_at": "2017-01-05T13:24:47.928Z"
  }
},
{
  "model": "survey.answer",
  "pk": 59,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 1,
    "hcp_category": 3,
    "survey": 1,
    "data": {
      "csrfmiddlewaretoken": [
        "r1QLbTgjp8oABF34o4WgjIhbZC5yQxYqvdn3luUmcktgHYquhnupBZGRUcUnDc6f"
      ],
      "data[4][]": [
        "Preference of the patients",
        "Pre-dominancy of Symptoms",
        "Tolerability profile",
        "Mechanism of Action"
      ],
      "data[4][other]": [
        ""
      ],
      "data[6][other]": [
        ""
      ],
      "data[1][additional]": [
        "0"
      ],
      "data[3][]": [
        "Resperidol-LAI",
        "Resperidol-oral",
        "Aloperidol-LAI"
      ],
      "data[3][other]": [
        ""
      ],
      "data[2]": [
        "No"
      ]
    },
    "created_at": "2017-01-05T13:25:49.440Z"
  }
},
{
  "model": "survey.answer",
  "pk": 60,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 2,
    "organization": 2,
    "hcp_category": 1,
    "survey": 1,
    "data": {
      "data[3][other]": [
        ""
      ],
      "data[7]": [
        "Yes"
      ],
      "csrfmiddlewaretoken": [
        "wLHLFvCyuEa17lxTO5qbVF7OH4A3Gc2NjuYVFL62Z6QWlbK3LB9eEaVVJyKFZ9Jk"
      ],
      "data[5]": [
        "No"
      ],
      "data[6][]": [
        "Pre-dominancy of Symptoms"
      ],
      "data[1][additional]": [
        "1"
      ],
      "data[4][other]": [
        ""
      ],
      "data[6][other]": [
        ""
      ],
      "data[3][]": [
        "Resperidol-LAI"
      ],
      "data[4][]": [
        "Efficacy profile"
      ],
      "data[2]": [
        "No"
      ]
    },
    "created_at": "2017-01-05T13:47:28.046Z"
  }
},
{
  "model": "survey.answer",
  "pk": 61,
  "fields": {
    "user": 1,
    "country": 3,
    "region": 1,
    "organization": 2,
    "hcp_category": 3,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-05T13:49:35.160Z"
  }
},
{
  "model": "survey.answer",
  "pk": 62,
  "fields": {
    "user": 1,
    "country": 3,
    "region": 2,
    "organization": 2,
    "hcp_category": 3,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-05T14:23:21.633Z"
  }
},
{
  "model": "survey.answer",
  "pk": 63,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 2,
    "organization": 2,
    "hcp_category": 2,
    "survey": 1,
    "data": {
      "data[4][]": [
        "Tolerability profile",
        "Mechanism of Action",
        "Health care system specific",
        "Age"
      ],
      "data[4][other]": [
        ""
      ],
      "data[1][additional]": [
        ""
      ],
      "data[6][]": [
        "Mechanism of Action",
        "Efficacy profile",
        "Preference of the patients"
      ],
      "data[6][other]": [
        ""
      ],
      "data[3][]": [
        "Ari-LAI",
        "Quetapin-oral",
        "Ari-oral",
        "Aloperidol-LAI",
        "Paliperidone-oral"
      ],
      "data[3][other]": [
        ""
      ],
      "csrfmiddlewaretoken": [
        "GrBTanCyHVZtfKXDlkg4n2mPFYfjWOHJXEllIhWFj2Y9z2KYd7nnbID4eIC2ZaTu"
      ]
    },
    "created_at": "2017-01-06T08:31:53.322Z"
  }
},
{
  "model": "survey.answer",
  "pk": 64,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 2,
    "organization": 2,
    "hcp_category": 2,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-06T09:05:42.388Z"
  }
},
{
  "model": "survey.answer",
  "pk": 65,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 2,
    "organization": 2,
    "hcp_category": 3,
    "survey": 1,
    "data": {
      "data[7]": [
        "No"
      ],
      "data[4][other]": [
        ""
      ],
      "data[6][other]": [
        ""
      ],
      "data[1][additional]": [
        ""
      ],
      "data[3][other]": [
        "Penicilin,Paracetamlol Plus"
      ],
      "data[3][]": [
        "Paliperidone-oral",
        "Resperidol-oral",
        "Aloperidol-LAI"
      ],
      "data[4][]": [
        "Age",
        "Tolerability profile",
        "Preference of the patients"
      ],
      "data[5]": [
        "No"
      ],
      "data[6][]": [
        "Preference of the patients",
        "Age",
        "Efficacy profile"
      ],
      "data[2]": [
        "No"
      ],
      "csrfmiddlewaretoken": [
        "ecaQQnV2o8HgI2PD69hOz2FWFRL3fppSzDFGghqXrtbOexTmF0k4zmyoquxMx7u2"
      ],
      "data[1][main]": [
        "11"
      ]
    },
    "created_at": "2017-01-06T09:08:30.626Z"
  }
},
{
  "model": "survey.answer",
  "pk": 66,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 3,
    "organization": 2,
    "hcp_category": 3,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-06T09:12:27.197Z"
  }
},
{
  "model": "survey.answer",
  "pk": 67,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 2,
    "organization": 1,
    "hcp_category": 3,
    "survey": 1,
    "data": {
      "data[1][main]": [
        ""
      ],
      "data[6][other]": [
        ""
      ],
      "data[4][other]": [
        ""
      ],
      "data[1][additional]": [
        ""
      ],
      "csrfmiddlewaretoken": [
        "v6zIVBVeAQvzAnA5otUHxIeVB4BTd0D4Qx4ylvq9DbZ76SEOXkXXx27nmHnCvIIe"
      ],
      "data[3][other]": [
        ""
      ]
    },
    "created_at": "2017-01-06T09:18:05.017Z"
  }
},
{
  "model": "survey.answer",
  "pk": 68,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 2,
    "organization": 2,
    "hcp_category": 3,
    "survey": 1,
    "data": {
      "data[7]": [
        "Yes"
      ],
      "data[1][main]": [
        ""
      ],
      "data[6][other]": [
        ""
      ],
      "data[4][other]": [
        ""
      ],
      "data[1][additional]": [
        ""
      ],
      "csrfmiddlewaretoken": [
        "hZFomgnwpokodUk0BDIpBPDdvYpToJmWCqaeMaSrsJOWJpoJauLFB9wFgBbCGrr6"
      ],
      "data[3][other]": [
        ""
      ]
    },
    "created_at": "2017-01-06T09:18:33.489Z"
  }
},
{
  "model": "survey.answer",
  "pk": 69,
  "fields": {
    "user": 2,
    "country": 3,
    "region": 1,
    "organization": 2,
    "hcp_category": 1,
    "survey": 1,
    "data": {},
    "created_at": "2017-01-06T09:33:56.271Z"
  }
}
]
